PharmaShots | Incisive News in 3 Shots

Subscribe Now

F2G

Insights+: Breakthrough Therapy Designation by the US FDA in 2020

Insights+: Breakthrough Therapy Designation by the US FDA in 2020

March 11, 2021

Insights+: Breakthrough Therapy Designation by the US FDA in 2019

Insights+: Breakthrough Therapy Designation by the US FDA in 2019

March 13, 2020

F2G's Olorofim Receives the US FDA's Breakthrough Therapy Designation to Treat Invasive Mold Infections in Patients with Limited or No Treatment Options

F2G's Olorofim Receives the US FDA's Breakthrough Therapy Designation to Treat Invasive Mold Infections in Patients with Limited o...

November 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us